Functionally, we measured in vivo glucose transport in the CAFs by injecting in the tumor-bearing mice the fluorescent glucose analog 2-NBDG and confirmed that CD73+ glyCAF exhibit increased glucose uptake compared to CD73− non-glyCAF (Supplementary Fig. 3e). Here, NT5E is linked to neoplasm.